SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES for SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Suport for free trade agreements with Panama, South Korea, and Columbia before the 111th Congress. Support for Congressional action to establish the Trans-Pacific Partnership initiative by the White House.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM ALLMOND | — |
| JUSTINE FREISLEBEN | — |
| DANIEL MOSS | — |
| ELIZABETH ANN STEVULAK | — |
Taxation/Internal Revenue Code TAX
Section 179 of the Internal Revenue Code, provisions related to bonus depreciation deduction. HR 4213, American Workers, State, & Business Relief Act of 2010, provision to renew the research and development tax credits.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM ALLMOND | — |
| JUSTINE FREISLEBEN | — |
| MICHAEL F KENNEDY | — |
| DANIEL MOSS | — |
| DANIEL NEWTON | — |
| ELIZABETH ANN STEVULAK | — |
Environment/Superfund ENV
S. 3209, the Safe Chemicals Act of 2010, provisions related to establishment of a safety standard, requirements for a minimum data set, and confidential business information. The Toxic Chemicals Safety Act of 2010 not yet formally introduced by the House, provisions related to estabishment of a safety standard and requirements for a minimum data set, and confidential business information. Section 108(b) of the Comprehensive Environmental Response, Compensation, and Liability Act, provision related to financial assurance. Section 112(k) of the Clean Air Act, provisions related to the Chemical Manufacturers Area Sources standards final rule. Section 112(d) of the Clean Air Act, provisions related to the regulation of industrial boilers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM ALLMOND | — |
| JUSTINE FREISLEBEN | — |
| MICHAEL F KENNEDY | — |
| DANIEL MOSS | — |
| DANIEL NEWTON | — |
| ELIZABETH ANN STEVULAK | — |
Labor Issues/Antitrust/Workplace LBR
HR 2067 & S. 1580, Protect America's Workers Act, provisions related to employer abatement, penalties for non-compliance, and due process.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM ALLMOND | — |
| MICHAEL F KENNEDY | — |
| DANIEL MOSS | — |
| ELIZABETH ANN STEVULAK | — |
Pharmacy PHA
HR 4816, the Food and Drug Administration Improvement Act of 2010, provisions related to providing the Food and Drug Administration with resources to ensure safety of drugs imported into the US from foreign countries. HR 759, the Food and Drug Administration Globalization Act of 2009, provisions to expand FDA's authority to inspect foreign drug facilities. S. 882, the Drug and Device Accountability Act of 2009, provisions to expand FDA's authority to inspect foreign drug facilities.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM ALLMOND | — |
| JUSTINE FREISLEBEN | — |
| DANIEL MOSS | — |
| ELIZABETH ANN STEVULAK | — |
Tariff (miscellaneous tariff bills) TAR
General support for passage of the Miscellaneous Tariff Bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM ALLMOND | — |
| JUSTINE FREISLEBEN | — |
| DANIEL MOSS | — |
| ELIZABETH ANN STEVULAK | — |
Homeland Security HOM
H.R. 2868, the Chemical and Water Security Act of 2009, provisions related to inherently safer technology. S. 2996 & HR 5186, the Continuing Chemical Facilities Antiterrorism Security Act of 2010, provisions to authorize a mult-year extension of the existing Chemical Facility Antiterrorism Act standards. S. 3480, the Protecting Cyberspace as a National Asset Act of 2010, discussion about why cyber security is important to SOCMA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM ALLMOND | — |
| JUSTINE FREISLEBEN | — |
| MICHAEL F KENNEDY | — |
| DANIEL MOSS | — |
| DANIEL NEWTON | — |
| ELIZABETH ANN STEVULAK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.